Back to Search
Start Over
PO81 - Ribociclib and Endocrine Therapy (ET) in Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2-Negative (HER-2) Breast Cancer: The Monaleesa Clinical Trials Program.
- Source :
- Breast; 2017 Supplement 1, Vol. 36, pS50-S50, 1p
- Publication Year :
- 2017
- Subjects :
- HORMONE therapy
EPIDERMAL growth factor receptors
BREAST cancer
Subjects
Details
- Language :
- English
- ISSN :
- 09609776
- Volume :
- 36
- Database :
- Supplemental Index
- Journal :
- Breast
- Publication Type :
- Academic Journal
- Accession number :
- 126043071
- Full Text :
- https://doi.org/10.1016/S0960-9776(17)30700-2